Quality of systematic reviews of economic evaluations in health care

JAMA

Volumn 287, Issue 21, 2002, Pages 2809-2812

  Jefferson, Tom ^a,b   Demicheli, Vittorio ^a,c   Vale, Luke ^a,d  

^a Cochrane Health Economics Methods Group ^*  (Italy)

^b Reviewer Cochrane Collaboration   (Italy)

^c Health Economics Research Unit ^*  (Italy)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ECONOMIC EVALUATION; HEALTH CARE; METHODOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW;

EID: 0037024303     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.287.21.2809     Document Type: Review

References (53)

1. Health care cost-benefit analysis and cost-effectiveness analysis from 1979 to 1990: A bibliography
2. Health care cost-benefit analysis and cost-effectiveness analysis from 1991 to 1996: An update
3. Guidelines for authors and peer-reviewers of economic submissions to the British Medical Journal
4. Are guidelines for peer-reviewing economic evaluations necessary? a survey of current editorial practice
5. Peer review of economic submissions
6. Identifying systematic reviews in MEDLINE: Developing an objective approach to search strategy design
7. Users' guides to the medical literature, VI: How to use an overview
8. Validation of an index of the quality of review articles
9. A tool to improve quality of reporting published economic analysis
10. Recommendations of the panel on cost-effectiveness in health and medicine
11. Recommendations for reporting cost-effectiveness analyses
12. Reporting cost-effectiveness studies and results
13. Handling uncertainty when performing economic evaluations of healthcare interventions
14. Analysis and interpretation of cost data in randomised controlled trials: Review of published studies
15. A review of the use of health status measures in economic evaluation
16. Health care contingent valuation studies: A review and classification of the literature
17. Economic analysis in randomised controlled trials
18. Twenty years of health care economic evaluations in Spain: Are we doing well?
19. Economic assessment of drugs in Spain
20. Methodological principles of cost analyses in the nursing, medical, and health services literature, 1990-1996
21. Problems with the interpretation of pharmacoeconomic analyses: A review of submissions to the Australian Pharmaceutical Benefits Scheme
22. Cost-effectiveness and cost-benefit analyses in the medical literature: Are methods being used correctly?
23. An exploratory review of the economics of recombinant vaccines against hepatitis B
24. Is vaccination against hepatitis B efficient? a review of world literature
25. Economic evaluation of mental health care interventions: A review
26. Economic evaluation in stroke research: A systematic review
27. Economic evaluations of technologies to minimize perioperative transfusion: A systematic review of published studies
28. Economic evaluation studies in nuclear medicine: A methodological review of the literature
29. A systematic review of cost-effectiveness research of stroke evaluation and treatment
30. Assessing the potential cost-effectiveness of pneumococcal vaccines: Methodological issues and current evidence
31. Economic evaluation of influenza vaccination and economic modelling: Can results be pooled?
32. Secondary analysis of economic data: A review of cost-benefit studies of neonatal screening for phenylketonuria
33. Recent economic evaluations of antenatal screening: A systematic review and critique
34. Economic evaluations in the hip arthroplasty literature: Lessons to be learned
35. Costing vascular surgery: A review of current reporting practice
36. Systematic review on the cost-effectiveness of public health interventions for HIV prevention in industrialised countries
37. Analysis of the eligibility of published economic evaluations for transfer to a given health care system: Methodological approach and application to the French health care system
38. Economic evaluation of cholesterol-related interventions in general practice: An appraisal of the evidence
39. Economic evaluation of parasitic diseases: A critique of the internal and external validity of published studies
40. Economic evaluation of communicable disease interventions in developing countries: A critical review of the published literature
41. The use of QALY and non-QALY measures of health-related quality of life: Assessing the state of the art
42. Systematic overview of cost-utility assessments in oncology
43. Cost-utility in practice: A policy maker's guide to the state of the art
44. A tool to improve quality of reporting published economic analysis
45. The quality of reporting in published cost-utility analyses, 1976-1997
46. Benefit valuation in economic evaluation of cancer therapies: A systematic re view of the published literature
47. The measurement of indirect costs in the health economics evaluation literature
48. Equity and the economic evaluation of healthcare
49. Measuring cost-utility analyses
50. Pharmacoeconomic analyses: Making them transparent, making them credible